Gregory William Endres

This inventor holds 22 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 9 EPO patents. Top assignees: Cayman Chemical Company Incorporated, Myometrics LLC, Pinpoint Testing, LLC. Active years: 2002-2024.

USPTO Granted Patents = 22 (Patent Applications = 7)

% Patents Active = 63.6

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 41(Granted Patents)

Company Filing History:

20 out of 29

Cayman Chemical Company Incorporated

Pinpoint Testing, LLC

patent

4. 1 out of 3,511

University of Michigan

patents

5. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2024

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12019002 - Ready-to-extract platforms for chemical analysis and quantification of unknown samples using spiked matrix standards (2024-06-25),

2. 11884624 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2024-01-30),

3. 11066361 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2021-07-20),

4. 10729810 - Methods, systems, and compositions for promoting bone growth (2020-08-04),

5. 10556862 - Difluorolactam compounds as EPreceptor-selective agonists for use in the treatment of EP-mediated diseases and conditions (2020-02-11),

6. 10450257 - Methods of synthesizing a prostacyclin analog (2019-10-22),

7. 10155716 - Amine salts of a prostacyclin analog (2018-12-18),

8. 9908834 - Methods of synthesizing a prostacyclin analog (2018-03-06),

9. 9890104 - Amine salts of a prostacyclin analog (2018-02-13),

10. 9701630 - [object Object] (2017-07-11),

11. 9688627 - [object Object] (2017-06-27),

12. 9676712 - [object Object] (2017-06-13),

13. 9487478 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2016-11-08),

14. 9440919 - Difluorolactam compositions for EP4-mediated osteo related diseases and conditions (2016-09-13),

15. 9180116 - Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions (2015-11-10),

Title: The Innovative Journey of Gregory William Endres

Introduction: Gregory William Endres, a talented inventor hailing from Saline, MI (US), has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Gregory William Endres holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing new solutions to complex problems.

Career Highlights: Throughout his illustrious career, Gregory William Endres has demonstrated a keen ability to identify gaps in the market and develop innovative products that meet the needs of consumers. His dedication to pushing the boundaries of technology has led to the successful commercialization of several of his inventions.

Collaborations: Gregory William Endres has collaborated with leading tech companies and research institutions to further enhance his inventions and bring them to the market. His collaborative spirit and passion for innovation have been instrumental in his success as an inventor.

Conclusion: Gregory William Endres continues to inspire aspiring inventors with his remarkable achievements and unwavering commitment to innovation. His impact on the technological landscape is truly commendable, and his legacy as an inventor will undoubtedly endure for years to come.